Bibliography | 1. Yang, Y., Bu, D., Zhao, X., Sun, P., Wang, J., & Zhou, L. (2013). Proteomic analysis of cow, yak, buffalo, goat and camel milk whey proteins: quantitative differential expression patterns. Journal of Proteome Research, 12(4), 1660–1667. https://doi.org/10.1021/pr301001m. 2. Xiu, P., Dong, X., Dong, X., Xu, Z., Zhu, H., Liu, F., … Sun, X. (2013). Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma. Cancer Science, 104(3), 375–382. https://doi.org/10.1111/cas.12088. 3. Hettinga, K., van Valenberg, H., de Vries, S., Boeren, S., van Hooijdonk, T., van Arendonk, J., & Vervoort, J. (2011). The host defense proteome of human and bovine milk. PloS One, 6(4), e19433. https://doi.org/10.1371/journal.pone.0019433. 4. Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., … Amouyel, P. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nature Genetics, 41(10), 1094–1099. https://doi.org/10.1038/ng.439. 5. Stewart, E. M., Aquilina, J. A., Easterbrook-Smith, S. B., Murphy-Durland, D., Jacobsen, C., Moestrup, S., & Wilson, M. R. (2007). Effects of glycosylation on the structure and function of the extracellular chaperone clusterin. Biochemistry, 46(5), 1412–1422. https://doi.org/10.1021/bi062082v. 6. Wang, X., Zou, F., Zhong, J., Yue, L., Wang, F., Wei, H., … Xiu, P. (2018). Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma. Journal of Cancer, 9(8), 1403–1413. https://doi.org/10.7150/jca.23849. 7. Zhong, J., Yu, X., Dong, X., Lu, H., Zhou, W., Li, L., … Shi, X. (2018). Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals. International Journal of Molecular Medicine, 41(5), 2893–2900. https://doi.org/10.3892/ijmm.2018.3463. 8. Wang, C., Jiang, K., Kang, X., Gao, D., Sun, C., Li, Y., … Liu, Y. (2012). Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis. The International Journal of Biochemistry & Cell Biology, 44(12), 2308–2320. https://doi.org/10.1016/j.biocel.2012.09.012. 9. Trougakos, I. P., & Gonos, E. S. (2006). Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radical Research, 40(12), 1324–1334. https://doi.org/10.1080/10715760600902310. 10. Lourda, M., Trougakos, I. P., & Gonos, E. S. (2007). Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J. International Journal of Cancer, 120(3), 611–622. https://doi.org/10.1002/ijc.22327. 11. Han, Z., Wang, Z., Cheng, G., Liu, B., Li, P., Li, J., … Zhang, W. (2012). Presence, localization, and origin of clusterin in normal human spermatozoa. Journal of Assisted Reproduction and Genetics, 29(8), 751–757. https://doi.org/10.1007/s10815-012-9779-x. 12.Wilson MR, Zoubeidi A. Clusterin as a therapeutic target. Expert Opin Ther Targets. 2017 Feb;21(2):201-213. doi: 10.1080/14728222.2017.1267142. Epub 2016 Dec 16. PMID: 27978767. |